Close
4

Quotient Sciences Quotient Sciences

X

Company profile for Trevi Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
We are developing nalbuphine ER to treat serious neurologically mediated conditions by targeting the central and peripheral nervous systems. Nalbuphine ER is an oral, extended-release formulation of nalbuphine, which has a long history of efficacy and safety, having been approved for more than 20 years in the United States and Europe as a subcutaneous injection for relief of moderate to severe pain in the hospital setting. ...
We are developing nalbuphine ER to treat serious neurologically mediated conditions by targeting the central and peripheral nervous systems. Nalbuphine ER is an oral, extended-release formulation of nalbuphine, which has a long history of efficacy and safety, having been approved for more than 20 years in the United States and Europe as a subcutaneous injection for relief of moderate to severe pain in the hospital setting. Our novel oral formulation is unlocking new market opportunities and the potential to significantly improve the quality of life of patients who currently have few treatment options.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Trevi Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
195 Church Street, 14th Floor New Haven, CT 06510
Telephone
Telephone
(203) 304-2499
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY